Medable vs Gene Doe
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
Medable
This app connects participants to clinical trials, providing a comprehensive eCOA solution. It facilitates digital data collection, ePRO, eDiaries, visit scheduling, and televisits. Users receive notifications and access trial resources, with potential integrations for sensors and wearables.
- Digital data collection
- Electronic patient-reported outcome (ePRO)
- eDiaries and questionnaires
- Visit and activity scheduling
- Televisit capabilities
- Notifications and reminders
- Trial resources access
Read full descriptionHide full description
Medable is on a mission to enable effective therapies to people faster. The Medable app connects people to their sponsors’ clinical trials, offering a complete eCOA solution that includes: - Digital data collection - Electronic patient-reported outcome (ePRO) - eDiaries and questionnaires - Schedule of your visits and activities - Televisit - Notifications and reminders - Trial resources - Integrations with select sensors, wearables, and more.
Gene Doe
This platform enables citizen science by connecting users with research studies. Researchers can publish protocols and collect data via HealthKit and ResearchKit, while users can enroll in studies after meeting screening requirements and providing consent.
- Citizen science platform
- Research study participation
- Data collection via HealthKit
- ResearchKit ActiveTasks integration
- Self-enrollment in studies
Read full descriptionHide full description
Gene Doe is a platform for citizen science. Researchers self-publish their protocols using REDCap, and can include instructions to capture patient reported outcomes, sensor and other data in HealthKit, and results of ResearchKit ActiveTasks. Interested app users who meet screening requirements and provide informed consent self-enroll into these studies.
Screenshots
Verdict
The clearest difference is rating: Medable at 4.7 against Gene Doe's 4.0. Medable also leads on update cadence (every 2 weeks vs every 4 weeks) and ratings volume (17 vs 3). On price, ads, in-app purchases and monetization model there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
Medable holds the better App Store score, 4.7 against 4.0. That said, the two scores are not equally well evidenced: Medable has 17 ratings behind it against 3, so its average is the more settled of the two.
Medable ships an update every 2 weeks, Gene Doe every 4 weeks. The most recent releases landed on September 27, 2026 and June 1, 2026 respectively.
| Parameter | Medable | Gene Doe |
|---|---|---|
| Price | Free | Free |
| Rating | 4.7 (17 ratings) — better | 4.0 (3 ratings) |
| Positive reviews | 50.0% of reviews | — |
| Number of ratings | 17 — better | 3 |
| Update frequency | Every 2 weeks — better | Every 4 weeks |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | Free |
| Devices | iPhone, iPad | iPhone, iPod, Apple Watch — better |
| Requires iOS | 16.5 | 15.6 — better |
| Further details — not scored | ||
| Size | 114 MB | 48 MB |
| Age rating | 4+ | 12+ |
| Developer | Medable, Inc. | Christopher Metts |
Customer experience
Medable
Gene Doe
In-app purchases
Medable
No in-app purchases
Gene Doe
No in-app purchases
